Science & Technology
SBIR Phase II:Clinical scale and testing of the first virus-free precision gene edited cell therapy for veterinary oncology
National Science Foundation
Opportunity #: 2243587
Award Ceiling
$974K
Award Floor
$974K
Close Date
Sep 30, 2025
Total Funding
$974K
Expected Awards
1
Posted Date
Oct 1, 2023
Cost Sharing Required
No
Grants.gov ID
sbir-2243587
Description
SBIR Phase Phase II award: "SBIR Phase II:Clinical scale and testing of the first virus-free precision gene edited cell therapy for veterinary oncology" awarded to LifEngine Animal Health Laboratories Incorporated in Eagan, Minnesota. Funded by National Science Foundation. Award amount: $973,924. The SBIR/STTR programs fund innovative research and development by small businesses, with Phase I for feasibility studies and Phase II for full R&D.
Eligible Applicants
Small businesses
Apply on Grants.gov
Always verify details and apply through the official Grants.gov portal. Information here may not reflect the latest changes.
View on Grants.govDisclaimer: This information is sourced from Grants.gov and may not reflect the most current details. Always verify eligibility requirements, deadlines, and application procedures on the official program website before applying.